Celldex Therapeutics Stock Price

-0.06 (-0.3%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Celldex Therapeutics Inc CLDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -0.3% 20.05 00:00:01
Open Price Low Price High Price Close Price Prev Close
19.49 19.10 20.4612 20.06 20.11
Bid Price Ask Price Spread News
16.15 20.05 3.90 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,167 892,323 $ 19.94 $ 17,795,225 675,898 1.50 - 23.40
Last Trade Time Type Quantity Stock Price Currency
18:57:06 formt 100 $ 20.05 USD

Celldex Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 793.32M 39.57M 39.55M $ 3.57M $ - -3.58 -8.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Celldex Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0620.6417.3118.84699,7841.9911.02%
1 Month17.2220.6416.0317.97610,6142.8316.43%
3 Months16.3323.4015.9318.91669,6983.7222.78%
6 Months10.8023.409.5915.86665,1049.2585.65%
1 Year2.2823.401.509.911,204,82217.77779.39%
3 Years2.8623.400.173.681,354,61217.19601.05%
5 Years10.0023.400.173.801,645,38210.05100.5%

Celldex Therapeutics Description

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.

Your Recent History
Celldex Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.